Big pharma looks beyond virus as AstraZeneca eyes Gilead
Bloomberg Two drugmakers behind the industry’s most prominent responses to the Covid-19 pandemic are looking into the possibility of a combined future as economies emerge from lockdowns. AstraZeneca Plc, co-developer of one of the fastest-moving experimental coronavirus vaccines, has made a preliminary approach to Gilead Sciences Inc., maker of the only US-approved treatment, according to people familiar with the matter. ...
Read More »